An observational study in Inflammatory Bowel Diseases, Cardiovascular Diseases and Inflammation, sponsored by I.M. Sechenov First Moscow State Medical University. Completed at 1 site in Russia. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-12.
Sponsored by I.M. Sechenov First Moscow State Medical University · Observational
The study will show the influence of inflammatory bowel disease on the risk of development of atherosclerosis
1,460 studies on the registry are indexed under Inflammatory Bowel Diseases; 437 are open to participants now.
This study's enrollment of 115 is below the median of 139 across 645 observational studies indexed under Inflammatory Bowel Diseases.
Browse Inflammatory Bowel Diseases studies →I.M. Sechenov First Moscow State Medical University is the lead sponsor of 133 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
50 patients with ulcerative colitis, 50 patients with Crohn disease, 50 patients without inflammatory bowel disease
Exclusion Criteria:
Intima-media thickness
Intima-media thickness
Time frame: 1 year
Pulse wave velocity
Pulse wave velocity
Time frame: 1 year
All cause mortality
Time frame: 1 year
Cardiovascular mortality
Time frame: 1 year
Hospitalisation due to cardiovascular disease
Time frame: 1 year
Plan to share: Undecided
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
I.M. Sechenov First Moscow State Medical University